Webinar | December 23, 2016

How To Make Novel Therapies A Reality In Tomorrow's Complex Biopharma Landscape

Source: MilliporeSigma

A recent survey conducted by the Economist Intelligence Unit highlights the new products that the biopharma industry identifies as most disruptive to their growth strategies in the next five years. The findings raise a challenge to biopharma to go beyond barriers to bringing new products to market by presenting ways to overcome these hurdles and make novel therapies a reality.